ArticleFrontiers in sleep2025
Effects of complete home-based biofeedback therapy on insomnia disorders in patients with cancer.
Article in Frontiers in sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Physical factor therapies for insomnia: a narrative review of mechanisms, clinical evidence, and phenotype-guided applications.Frontiers in psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Professional palliative care for patients with cancer focuses on symptom management. Methods: This exploratory, randomized controlled study was conducted to compare the effects of complete home-based heart rate variability biofeedback (HRV-BFB) using an estimation formula for resonance frequency in managing insomnia disorders among patients with cancer. Results: Only 28 patients were included from the initial enrollment of 30 patients from two study sites. Results showed that compared to the control group, the HRV-BFB group improved sleep efficiency from 82.0% (standard deviation: 9.1%) to 87.8% (standard deviation: 7.2%) ( Conclusions: This suggests that complete home-based HRV-BFB using an estimation formula for resonance frequency may be a promising tool for treating insomnia disorders in patients with cancer, potentially improving sleep efficiency and decreasing reliance on sleep medications. Clinical trial registration: UMIN 000046884. Registered February 11, 2022. https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000053496.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.